Quantum Cyber N.V. (QUCY)
NASDAQ: QUCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
QUCY stock chart
Technical analysisKey statistics
All statistics- Market cap
- $44.67M
- EPS (TTM)
- -$2.27
- Dividend yield
- None
- 52-week range
- 0.30 – 4.93
- Day range
- 0.5108 – 0.5786
- Volume / Avg
- 301.92K / 528.02K
- Beta
- —
- Shares outstanding
- 87.24M
52-week range
QUCY stock today
On Nov 20, QUCY ended the session at $0.512, shedding $0.04 (7.25%), versus the S&P 500's 3.70% decline. At this level, QUCY sits near the bottom of its 52-week range of $0.30 to $4.93: 89.6% below the high, set on May 15, 2026 and 70.7% above the low. QUCY is down 54.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 48.7%.
Quantum Cyber N.V. has posted a net loss over the last twelve months (EPS of -$2.27), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Quantum Cyber N.V.
Company profileQuantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. David Elliot Lazar
- Headquarters
- Mainz
- Employees
- 10
- IPO year
- 2021
- Website
- quantum-cyber.ai
Financial highlights
Full financialsIn fiscal 2025, Quantum Cyber N.V. generated $537,080 in revenue, down 39.9% from fiscal 2024, its first annual decline since 2024. Quantum Cyber N.V. reported a net loss of $16.2 million, compared with a loss of $21.6 million a year earlier. Gross margin was 72.6% (up from 64.3%) and operating margin -3005.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $537.08K | $893.99K | $895.48K | $529.88K | $577.35K |
| Growth | -39.92% | -0.17% | +69.00% | -8.22% | +16.98% |
| Net income | $-16.21M | $-21.60M | $-26.34M | $-26.39M | $-11.69M |
| EPS (diluted) | $-2.70 | $-21.91 | $-64.76 | $-74.55 | $-1.62 |
Analyst forecast
ForecastConsensus (2 analysts)
none
Avg. price target
$9.00+1657.81%
- Strong buy 0
- Buy 1
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 13, 2026
- EPS actual vs est.
- $-0.08 vs $-0.08
- Surprise
- 0.00%
QUCY news
All QUCY news- Mainz Biomed N.V. Announces CFO Transition and Appoints David CaplonNasdaqQUCY, HEI.A
- Mainz Biomed N.V. Subsidiary Enters First Amendment to Intellectual Property License AgreementNasdaq
- Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David LazarGlobeNewswire
- Quantum Cyber Expands and Secures Exclusive Quantum Photonic Array License, Extending Its Quantum Layer Across Air, Surface and Subsea Unmanned Warfare DomainsGlobeNewswire
- Quantum Cyber Publishes Investor Explanatory Materials on Its Quantum Antenna Technology, Including Technical Summary and Companion VideoGlobeNewswire
- Quantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing ConveningGlobeNewswire
- Quantum Cyber Appoints Major General (Ret.) Alberto C. Rosende to Board of DirectorsGlobeNewswire
Quantum Cyber N.V. peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GANXGain Therapeutics Inc. | 0.9994 | -4.82% | $44.50M | vs QUCY |
| ANVSAnnovis Bio Inc. | 0.7113 | -4.96% | $44.12M | vs QUCY |
| APLMApollomics Inc. Class A | 15.54 | -6.92% | $45.28M | vs QUCY |
| RNXTRenovoRx Inc. | 0.942 | -10.29% | $45.45M | vs QUCY |
| HOWLWerewolf Therapeutics Inc. | 0.9466 | -3.97% | $46.00M | vs QUCY |
| RLYBRallybio Corporation | 15.47 | -0.32% | $43.32M | vs QUCY |
| SPROSpero Therapeutics Inc. | 0.742 | -10.20% | $43.23M | vs QUCY |
| MISTMilestone Pharmaceuticals Inc. | 0.3711 | -7.06% | $46.20M | vs QUCY |
Indexes, lists and sector
Quantum Cyber N.V. stock FAQ
What is Quantum Cyber N.V.'s stock price today?
QUCY last traded at $0.512 as of Nov 20, 4:00 PM EST, down 7.25% on the day. Prices are delayed at least 15 minutes.
Who is Quantum Cyber N.V.'s CEO?
Mr. David Elliot Lazar is the chief executive officer of Quantum Cyber N.V., which has about 10 employees.
What is the QUCY 52-week high?
The 52-week high for QUCY is $4.93 and the 52-week low is $0.30. The stock is currently 89.6% below its high.